Newsfiscal.ai
IceCure Medical Completes First Patient Treatment in ChoICE Post-Marketing Study
· Published
Article summary
IceCure Medical has successfully treated the first patient in its ChoICE post-marketing study, which evaluates the ProSense cryoablation system for treating low-risk breast cancer.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…